SGLT2 inhibitor trials for Heart failure

All SGLT2 inhibitor trials · All Heart failure trials

Phase breakdown

Recruiting trials studying SGLT2 inhibitor for Heart failure

• Effect of Sodium Glucose Co-tansporter 2 Inhibitors (SGLT2I) on Inflammatory and Oxidative Stress Markers Level in Heart Failure Patients
  NCT06585761 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
  NCT04899479 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning
  NCT06142474 · Phase: Phase 3 · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
  NCT07172971 · Phase: Phase 1 · Ages: 8 Years to 18 Years · Sex: Male · 1 location

Common questions

How many trials study SGLT2 inhibitor for Heart failure?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.